Shiv O'Neill - 01 Mar 2024 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Role
GC AND CORP SEC
Signature
/s/ Amy C. Seidel, as Attorney-in-Fact for Shiv O'Neill
Issuer symbol
ELAN
Transactions as of
01 Mar 2024
Net transactions value
-$21,705
Form type
4
Filing time
05 Mar 2024, 16:31:04 UTC
Previous filing
29 Feb 2024
Next filing
21 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELAN Common Stock Award $0 +15,596 +164% $0.000000 25,127 01 Mar 2024 Direct F1
transaction ELAN Common Stock Tax liability $21,705 -1,354 -5.4% $16.03 23,773 01 Mar 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELAN Employee Stock Option(right to buy) Award $0 +34,014 $0.000000 34,014 01 Mar 2024 Common Stock 34,014 $16.03 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted stock units pursuant to the Amended and Restated 2018 Elanco Stock Plan on March 1, 2024, one-third vesting on March 1, 2025, one-third vesting on March 1, 2026, and the remaining vesting on March 1, 2027.
F2 Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan.
F3 Grant of stock options vesting as follows: one-third vesting on March 1, 2025, one-third vesting on March 1, 2026, and the remaining vesting on March 1, 2027.